* Meta-terms correspond to biological or medical specialty concerned with one or more keywords (or keywords hierarchies), qualifiers, or resource types. Other terms also benefit from this structure, when the topic warrants it, eg education. See the list.

Doc'CISMeF search for this specility :


Preferred Label : gastroenterology;

Obsolete resource : false;

True Meta (CISMeF) : true;

Details


Main resources

You can consult :


https://ansm.sante.fr/actualites/avis-de-lansm-du-11-03-2024-sur-le-medicament-keytruda-dans-le-cadre-dune-demande-daap
2024
false
false
false
France
French
treatment outcome
pembrolizumab
Antineoplastic Agents, Immunological
drug information
Resectable Lung Non-Small Cell Carcinoma
carcinoma, non-small-cell lung
neoplasm recurrence, local
risk
pembrolizumab

---
https://ansm.sante.fr/tableau-marr/tacrolimus
2024
false
false
false
France
French
risk management
tacrolimus
tacrolimus
administration, oral
guidelines for drug use
patient education handout
continuity of patient care
immunosuppressive agents

---
https://www.has-sante.fr/jcms/p_3471694/fr/orkambi-lumacaftor/ivacaftor-mucoviscidose
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
lumacaftor, ivacaftor drug combination
drug combinations
ivacaftor
lumacaftor
ivacaftor and lumacaftor
infant
administration, oral
evaluation of the transparency committee
cystic fibrosis

---
https://www.has-sante.fr/jcms/p_3506437/fr/rubraca-rucaparib-cancer-de-l-ovaire
2024
false
false
false
France
fallopian tube neoplasms
peritoneal neoplasms
treatment outcome
insurance, health, reimbursement
administration, oral
rucaparib
evaluation of the transparency committee
rucaparib
ovarian neoplasms
Rucaparib Camsylate

---
https://www.has-sante.fr/jcms/p_3508868/fr/acide-tranexamique-tillomed-acide-tranexamique-antifibrinolytique
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
injections, intravenous
adult
adolescent
child
hemorrhage
hemorrhage due to fibrinolysis
drugs, generic
tranexamic acid
evaluation of the transparency committee
antifibrinolytic agents
tranexamic acid

---
https://ansm.sante.fr/tableau-marr/darvadstrocel
2024
false
false
false
France
French
risk management
Darvadstrocel
darvadstrocel
guidelines for drug use
guideline
medication errors
Darvadstrocel
drug storage
Infections
cold chain
temperature recording

---
https://ansm.sante.fr/actualites/campagne-vaccinale-contre-les-infections-a-papillomavirus-humains-hpv-les-donnees-recueillies-apres-la-premiere-dose-confirment-le-profil-de-securite-du-vaccin-gardasil-9
2024
false
false
false
France
French
papillomavirus vaccines
papillomavirus infections
vaccine safety
Human Papillomavirus Recombinant Vaccine nonavalent
mass vaccination
Vaccination Campaign
technical report
adolescent
vaccination

---
https://ansm.sante.fr/tableau-acces-derogatoire/bylvay
2024
false
false
false
France
French
insurance, health, reimbursement
odevixibat
odevixibat
summary of product characteristics
package leaflet
guidelines for drug use
infant
child
pruritus
cholestatic pruritus in Alagille syndrome
alagille syndrome

---
https://www.has-sante.fr/jcms/p_3486120/fr/tibsovo-ivosidenib-cancer-des-voies-biliaires
2024
false
false
false
France
locally advanced or metastatic cholangiocarcinoma with an IDH1 R132 mutation
adult
treatment outcome
insurance, health, reimbursement
cholangiocarcinoma
Locally Advanced Cholangiocarcinoma
Metastatic Cholangiocarcinoma
administration, oral
antineoplastic agents
ivosidenib
evaluation of the transparency committee
ivosidenib

---
https://www.has-sante.fr/jcms/p_3488172/fr/lynparza-olaparib-cancer-de-l-ovaire
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
olaparib
antineoplastic combined chemotherapy protocols
Bevacizumab/Olaparib Regimen
adult
Carcinoma, Ovarian Epithelial
Stage III Ovarian Cancer AJCC v6 and v7
Stage IV Ovarian Cancer AJCC v6 and v7
fallopian tube neoplasms
peritoneal neoplasms
administration, oral
evaluation of the transparency committee
olaparib

---
https://www.has-sante.fr/jcms/p_3478084/fr/zepatier-elbasvir/grazoprevir-hepatite-c-chez-les-adolescents-a-partir-de-12-ans
2024
false
false
false
France
evaluation of the transparency committee
adolescence
Hepatitis C Virus
hepatitis C
viral hepatitis c
Elbasvir/Grazoprevir
adolescent
Zepatier
Autonomic Nervous System
Teenager
Twelve
elbasvir-grazoprevir drug combination
Adolescents
Adolescent
Hepatitis C Infection
Algeria

---
https://www.has-sante.fr/jcms/p_3478096/fr/kalydeco-ivacaftor-mucoviscidose
2024
false
false
false
France
infant
child
evaluation of the transparency committee
ivacaftor
cystic fibrosis
ivacaftor
Ivacaftor
Cystic Fibrosis
cystic fibrosis
kalydeco
ivacaftor

---
https://www.has-sante.fr/jcms/p_3490839/fr/cufence-trientine-dichlorhydrate-maladie-de-wilson
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
administration, oral
chelating agents
trientine
adult
adolescent
child
evaluation of the transparency committee
trientine hydrochloride
hepatolenticular degeneration
trientine

---
https://ansm.sante.fr/tableau-acces-derogatoire/itraconazole
2024
false
false
false
France
French
itraconazole
guidelines for drug use
administration, oral
tinea
child
microsporum
antifungal agents
itraconazole
continuity of patient care

---
https://assurance-maladie.ameli.fr/etudes-et-donnees/2024-vedolizumab-ustekinumab-anti-tnf-grossesse-mici
2024
France
scientific and technical information
safety
TNF Gene
Ustekinumab
inflammatory bowel disease, nos
tumor necrosis factor
Institutional Review Board Independent Ethics Committee Notification of Safety Information Document
Physically Feel in Bad Condition
tumor necrosis factors
Safety Report
Clinical Trial Notification of Safety Information
chronic disease, nos
Vedolizumab
research report
vedolizumab
disease
Tumor Necrosis Factor
anti-TNF
Ustekinumab
Chronic Disease
pregnant women
inflammatory bowel diseases
vedolizumab
pregnancy, nos
albumin/globulin ratio
chronic disease
Gravida

---
https://ansm.sante.fr/actualites/decision-du-13-02-2024-cadre-de-prescription-compassionnelle-de-tibsovo-ivosidenib-250mg-comprime-pellicule
https://ansm.sante.fr/tableau-acces-derogatoire/ivosidenib
2024
false
false
false
France
French
drug information
administration, oral
ivosidenib
adult
glioma
guidelines for drug use
continuity of patient care
Unresectable Low Grade Glioma
Refractory Low Grade Glioma
IDH1 Gene Mutation
ivosidenib

---
https://ansm.sante.fr/tableau-marr/adalimumab
2024
false
false
false
France
French
Adalimumab
risk management
continuity of patient care
drug information
adult
child
patient education handout

---
https://www.has-sante.fr/jcms/p_3497062/fr/iomeron-iomeprol-produit-de-contraste-iode
2024
false
false
false
France
evaluation of the transparency committee
iodine, nos
iomeprol
contrast media
iomeprol
Iomeprol
iomeron
iomeprol
iodine

---
https://www.fcvd.fr/wp-content/uploads/2024/02/Information-avant-la-realisation-d-une-sphincterotomie-pour-fissure-anale.pdf
2024
France
patient education handout
achievement
fissure in ano
Anal Fissure, CTCAE
Sphincterotomy
No Information Available
anal fissure

---
https://www.fcvd.fr/wp-content/uploads/2024/02/Informations-avant-la-realisation-d-une-cure-chirurgicale-de-prolapsus-rectal-exteriorise-selon-Altemeier.pdf
2024
France
patient education handout
Continuing Umbrella of Research Experience for Underserved Minorities (CURE) Program
Informed
rectal prolapse
Oprelvekin
Cure Study
Rectal Prolapse
exteriorization
No Information Available
Tiaprofenic Acid
Expedited Report
Informative
achievement
rectal prolapse

---
https://www.fcvd.fr/wp-content/uploads/2024/02/Informations-avant-la-realisation-d-une-cure-de-fistule-anale-par-fistulotomie.pdf
2024
France
patient education handout
No Information Available
Cure Study
Oprelvekin
anal fistula
Informed
Anus Fistula, CTCAE
rectal fistula
incision of anal fistula
Informative
Continuing Umbrella of Research Experience for Underserved Minorities (CURE) Program
Anorectal Fistula
achievement
anal fistula

---
https://www.has-sante.fr/jcms/p_3497065/fr/visipaque-iodixanol-produit-de-contraste-iode
2024
false
false
false
France
iodixanol
-
-
evaluation of the transparency committee
iodine
iodixanol
contrast media

---
https://www.has-sante.fr/jcms/p_3497029/fr/xenetix-iobitridol-produit-de-contraste-iode
2024
false
false
false
France
iobitridol
evaluation of the transparency committee
contrast media
iodine
iobitridol

---
https://www.has-sante.fr/jcms/p_3498127/fr/dificlir-fidaxomicine-infection-a-clostridium-difficile
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
administration, oral
fidaxomicin
tablets
adult
anti-bacterial agents
time
evaluation of the transparency committee
Fidaxomicin
clostridium infections
Clostridium difficile Infections

---
https://www.has-sante.fr/jcms/p_3415645/fr/qinlock-ripretinib-tumeurs-stromales-gastro-intestinales
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
Advanced Gastrointestinal Stromal Tumor
Refractory Malignant Gastrointestinal Stromal Tumor
antineoplastic agents
ripretinib
administration, oral
evaluation of the transparency committee
gastrointestinal stromal tumors
ripretinib

---
https://www.has-sante.fr/jcms/p_3468175/fr/imfinzi-durvalumab-cancer-des-voies-biliaires
2024
false
false
false
France
Cisplatin/Durvalumab/Gemcitabine Regimen
treatment outcome
insurance, health, reimbursement
antineoplastic combined chemotherapy protocols
cisplatin
Gemcitabine
Unresectable Biliary Tract Carcinoma
Metastatic Biliary Tract Carcinoma
neoplasm metastasis
Antineoplastic Agents, Immunological
durvalumab
adult
guidelines for drug use
evaluation of the transparency committee
biliary tract cancer
biliary tract neoplasms
durvalumab

---
https://www.has-sante.fr/jcms/p_3498750/fr/keytruda-pembrolizumab-carcinome-a-cellules-renales
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
adult
antineoplastic combined chemotherapy protocols
clear cell renal cell carcinoma
Lenvatinib/Pembrolizumab Regimen
Advanced Clear Cell Renal Cell Carcinoma
infusions, intravenous
Antineoplastic Agents, Immunological
pembrolizumab
evaluation of the transparency committee
pembrolizumab
carcinoma, renal cell

---
https://www.has-sante.fr/jcms/p_3500260/fr/livmarli-maralixibat-syndrome-d-alagille
2024
false
false
false
France
Cholestatic pruritus (disorder)
treatment outcome
insurance, health, reimbursement
infant
child
administration, oral
pharmaceutical solutions
maralixibat chloride
Maralixibat Chloride
cholestatic pruritus in Alagille syndrome
evaluation of the transparency committee
alagille syndrome
maralixibat

---
https://www.has-sante.fr/jcms/p_3500210/fr/bylvay-odevixibat-prurit-cholestatique-associe-au-syndrome-d-alagille
2024
false
false
false
France
cholestatic pruritus in Alagille syndrome
Cholestatic pruritus (disorder)
treatment outcome
insurance, health, reimbursement
child
infant
administration, oral
odevixibat
evaluation of the transparency committee
odevixibat
alagille syndrome

---
https://www.inrs.fr/publications/bdd/eficatt/fiche.html?refINRS=EFICATT_Infections%20%C3%A0%20bact%C3%A9ries%20multir%C3%A9sistantes%20(BMR)%20digestives
2024
France
scientific and technical information
bacterium, nos
digestive tract function, nos
bacteria
gastrointestinal agents
digestion
digestants
digestant, nos
Basal Metabolic Rate
Percent of Bacteria
infectious disease, nos
Bacteria
Bacterial Count
Bacteria Present
Digestion
Infections
Infection

---
https://www.cochrane.org/fr/CD012608/LIVER_la-modification-de-lapport-en-graisses-alimentaires-est-elle-benefique-ou-risquee-pour-les-personnes
2024
United Kingdom
review of literature
french abstract
Dietary Route of Administration
gallstones
Modification
Alteration
Cholelithiasis
dietary fats
What Month is it
risk
Amendment
grease, nos
Amendment Regulatory Submission
biliary calculus, nos
persons
Data Change Date
Bile Duct Stone
People

---
https://www.inrs.fr/media.html?refINRS=QR%20181
2024
France
journal article
Involvement
risk
Hepatitis C Virus Positive
disease
hepatitis, nos
Fix
What Month is it
Disease Transmission
hepatitis
Hepatitis

---
https://www.cochrane.org/fr/CD012609/GUT_infliximab-pour-le-maintien-dun-traitement-efficace-dans-la-maladie-de-crohn
2024
United Kingdom
review of literature
french abstract
Treatment
Therapy Object
No Treatment for Diabetes
Infliximab
GDC Treatment Frequency Terminology
Until Effective
crohn disease
Maintenance
Infliximab Given for Kawasaki Disease
On Treatment
Treatment Study
Treatment Epoch
Infliximab
crohn's disease, nos
During Treatment
Treat
Biomaterial Treatment
Crohn Disease

---
https://dumas.ccsd.cnrs.fr/dumas-04492639
2024
France
dissertations, academic
patient escort service
counseling
crohn disease
has patient
Questionnaire Not Completed Due to Patient Illness
Crohn Disease
Transjugular Intrahepatic Portosystemic Shunt
crohn's disease, nos
disease

---
https://ansm.sante.fr/tableau-acces-derogatoire/keytruda-25-mg-ml-solution-a-diluer-pour-perfusion#
2024
false
false
false
France
French
drug information
triple negative breast neoplasms
pembrolizumab
pembrolizumab
summary of product characteristics
package leaflet
guidelines for drug use
adult
Early Stage Triple-Negative Breast Carcinoma
Locally Advanced Triple-Negative Breast Carcinoma
inflammatory breast neoplasms
Antineoplastic Agents, Immunological
endometrial neoplasms
clear cell renal cell carcinoma
renal cell carcinoma at increased risk of recurrence following nephrectomy, or following nephrectomy and resection of metastatic lesions

---
https://www.has-sante.fr/jcms/p_3443053/fr/enhertu-trastuzumab-deruxtecan-cancer-du-sein-her2
2024
false
false
false
France
adult
treatment outcome
insurance, health, reimbursement
Unresectable HER2-Positive Breast Carcinoma
Metastatic HER2-Positive Breast Carcinoma
neoplasm metastasis
trastuzumab deruxtecan
guidelines for drug use
Antineoplastic Agents, Immunological
infusions, intravenous
evaluation of the transparency committee
breast neoplasms
trastuzumab deruxtecan
Trastuzumab

---
https://ansm.sante.fr/tableau-acces-derogatoire/ivosidenib
2024
false
false
false
France
French
administration, oral
summary of product characteristics
cholangiocarcinoma
guidelines for drug use
leukemia, myeloid, acute
glioma
myelodysplastic syndromes
antineoplastic agents
ivosidenib
ivosidenib
neoplasm metastasis
package leaflet

---
https://ansm.sante.fr/tableau-acces-derogatoire/kaftrio-75-mg-50-mg-100-mg-comprime-pellicule-kalydeco-150-mg-comprime-pellicule
2024
false
false
false
France
French
cystic fibrosis
guidelines for drug use
continuity of patient care
drug therapy, combination
administration, oral
ivacaftor, tezacaftor and elexacaftor
elexacaftor, ivacaftor, tezacaftor drug combination
ivacaftor
tezacaftor
elexacaftor
adult
adolescent
ivacaftor
trikafta
drug combinations
drug information

---
https://www.cochrane.org/fr/CD015084/GUT_prebiotiques-pour-le-traitement-de-la-rectocolite-hemorragique
2024
United Kingdom
review of literature
french abstract
On Treatment
prebiotics
GDC Treatment Frequency Terminology
No Treatment for Diabetes
Treatment Epoch
hemorrhage, nos
Proctocolitis
colitis, ulcerative
Treatment Study
Treatment
Biomaterial Treatment
Hemorrhage
During Treatment
Therapy Object
proctocolitis, nos
Treat

---
https://www.cochrane.org/fr/CD013854/GUT_programmes-deducation-pour-les-patients-atteints-de-maladies-inflammatoires-chroniques-de-lintestin
2023
United Kingdom
review of literature
french abstract
Inflammatory disease
Chronic disease
chronic disease
chronically ill
appointments and schedules
schedules, patient
education
patient education as topic
disease
has patient
Diseases
chronic disease, nos
inflammatory bowel disease, nos
inflammatory bowel diseases

---
https://www.cochrane.org/fr/CD014821/GUT_lutilisation-de-la-technologie-pour-les-soins-distance-dans-les-maladies-inflammatoires-de-lintestin
2023
United Kingdom
review of literature
french abstract
inflammatory bowel diseases
Diseases
health services accessibility
nursing
Inflammatory disease
Technology
inflammatory bowel disease, nos
patient care
technology

---
https://www.has-sante.fr/jcms/p_3396878/fr/keytruda-pembrolizumab-cancer-du-sein-triple-negatif
2023
false
false
false
France
triple negative breast neoplasms
treatment outcome
insurance, health, reimbursement
Antineoplastic Agents, Immunological
pembrolizumab
antineoplastic combined chemotherapy protocols
infusions, intravenous
Locally Advanced Triple-Negative Breast Carcinoma
Early Stage Triple-Negative Breast Carcinoma
locally advanced triple negative breast cancer at high risk of recurrence
early stage triple negative breast cancer at high risk of recurrence
evaluation of the transparency committee
pembrolizumab

---
https://www.has-sante.fr/jcms/p_3409403/fr/keytruda-pembrolizumab-carcinome-a-cellule-renale
2023
false
false
false
France
chemotherapy, adjuvant
treatment outcome
insurance, health, reimbursement
pembrolizumab
infusions, intravenous
Antineoplastic Agents, Immunological
clear cell renal cell carcinoma
nephrectomy
clear cell renal cell carcinoma
renal cell carcinoma at increased risk of recurrence following nephrectomy, or following nephrectomy and resection of metastatic lesions
evaluation of the transparency committee
pembrolizumab
carcinoma, renal cell

---
https://www.has-sante.fr/jcms/p_3444608/fr/sequent-please-otw
2023
France
health technology assessment
paclitaxel
flatulence
tympanites
paclitaxel

---
https://www.youtube.com/watch?v=SL_z5ef8Bp4
2023
France
audiovisual aids
history
History
porcine species
swine
hepatitis, nos
hepatitis E
Hepatitis

---
https://www.snfge.org/sites/www.snfge.org/files/medias/documents/conseil_de_pratique_2023_manometrie_oesophagienne_hr.pdf
2023
false
false
false
France
scientific and technical information
esophageal manometry
chicago
classification
Motor system disorder
manometry
Motor Disorders
esophageal motor disorder, nos

---
https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2023-49/numero-6-juin-2023/enquete-hepatite-aigue-grave-enfants.html
2023
Canada
journal article
child, nos
Child
Child
liver
Child
severe
transplant, nos
hepatitis
data collection
child
Child
canada
acute hepatitis, nos
dataset
liver transplantation
detective
Hepatitis

---
https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2023-49/numero-6-juin-2023/hepatite-aigue-grave-origine-inconnue-enfants.html
2023
Canada
journal article
Child
child, nos
hepatitis
Child
Hepatitis
canada
acute hepatitis, nos
child
unknown (origin)
severe
Child
Child

---
https://www.has-sante.fr/jcms/p_3448228/fr/imjudo-/-imfinzi-tremelimumab-/-durvalumab-carcinome-hepato-cellulaire-chc
2023
false
false
false
France
antineoplastic combined chemotherapy protocols
Durvalumab/Tremelimumab Regimen
insurance, health, reimbursement
treatment outcome
infusions, intravenous
adult
Advanced Adult Hepatocellular Carcinoma
Unresectable Hepatocellular Carcinoma
Child-Pugh Class A
ECOG Performance Status 0
ECOG Performance Status 1
evaluation of the transparency committee
carcinoma, hepatocellular
durvalumab
tremelimumab

---
https://ansm.sante.fr/tableau-acces-derogatoire/ayvakyt
2023
false
false
false
France
French
administration, oral
avapritinib
avapritinib
drug information
aggressive systemic mastocytosis
mastocytosis, systemic
Systemic Mastocytosis with an Associated Myeloid Neoplasm
leukemia, mast-cell
adult

---
https://www.has-sante.fr/jcms/p_3447975/fr/enhertu-trastuzumab-deruxtecan-adenocarcinome-gastrique-ou-de-la-jonction-oesogastrique-jog
2023
false
false
false
France
French
evaluation of the transparency committee
treatment outcome
infusions, intravenous
stomach neoplasms
trastuzumab deruxtecan
Antineoplastic Agents, Immunological
trastuzumab deruxtecan
insurance, health, reimbursement

---
https://sesstim.univ-amu.fr/fr/video-box/seminaire-interne-marion-coste
2023
France
audiovisual aids
Senegal
attention
Applications
hepatitis B, chronic
senegal
health
senegalese
Applications
type b viral hepatitis
chronic hepatitis, nos
Applications
Hepatitis

---
https://sesstim.univ-amu.fr/fr/video-box/seminaire-interne-sylvie-boyer
2023
France
audiovisual aids
data collection
Hepatitis
nursing
hepatitis B, chronic
entrance
senegalese
Senegal
chronic hepatitis, nos
type b viral hepatitis
senegal

---
https://www.has-sante.fr/jcms/p_3451663/fr/opdivo-nivolumab-melanome
2023
false
false
false
France
Nivolumab
melanoma
evaluation of the transparency committee

---
https://www.has-sante.fr/jcms/p_3451969/fr/macrogol-4000-zydus-macrogol-laxatif-osmotique
2023
false
false
false
France
French
evaluation of the transparency committee

---
https://www.has-sante.fr/jcms/p_3451406/fr/imfinzi-durvalumab-cancer-des-voies-biliaires-cvb
2023
false
false
false
France
French
evaluation of the transparency committee
treatment outcome
Cisplatin/Durvalumab/Gemcitabine Regimen
durvalumab
Metastatic Biliary Tract Carcinoma
biliary tract neoplasms
Unresectable Biliary Tract Carcinoma
insurance, health, reimbursement
antineoplastic combined chemotherapy protocols
Antineoplastic Agents, Immunological
durvalumab

---
https://www.cochrane.org/fr/CD015133/NEONATAL_prebiotiques-pour-la-prevention-de-lenterocolite-necrosante-chez-les-prematures
2023
United Kingdom
review of literature
french abstract
infant, premature
immature
Necrotizing enterocolitis
prebiotics
enterocolitis, necrotizing

---
https://www.has-sante.fr/jcms/p_3456351/fr/actualisation-des-recommandation-et-obligations-vaccinales-des-professionnels
2023
France
evaluation of the transparency committee
influenza
measles
mumps, nos
chickenpox
whooping cough
Influenza
influenza, human
measles
chickenpox
pertussis
Hepatitis
hepatitis, nos
Varicella
Whooping cough
whooping cough
hepatitis
varicella, nos
mumps
Rubella
directive counseling
Measles
rubella, nos
influenza, nos
rubella
measles
mumps
rubella
Mumps

---
https://www.has-sante.fr/jcms/p_3456524/fr/sutent-sunitinib-tumeur-neuroendocrine-du-pancreas-pnet
2023
false
false
false
France
Unresectable Pancreatic Neuroendocrine Neoplasm
Metastatic Pancreatic Neuroendocrine Tumor
treatment outcome
insurance, health, reimbursement
protein kinase inhibitors
sunitinib
disease progression
adult
administration, oral
evaluation of the transparency committee
pancreatic neoplasms
neuroendocrine tumors
Sunitinib

---
https://www.has-sante.fr/jcms/p_3457061/fr/osperzo-mesalazine-rectocolite-hemorragique
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
mesalazine
administration, oral
Delayed-Action preparations
Product containing precisely mesalazine 3 gram/1 sachet prolonged-release oral granules (clinical drug)
Product containing precisely mesalazine 1.5 gram/1 sachet prolonged-release oral granules (clinical drug)
anti-inflammatory agents, non-steroidal
evaluation of the transparency committee
mesalamine
colitis, ulcerative

---
http://beh.santepubliquefrance.fr/beh/2023/15-16/2023_15-16_2.html
2023
France
journal article
Endoscopy
gastroenterology
endoscopy
endoscopy, nos
viral hepatitis c
Hepatitis
hepatitis C
consultants
outpatients
liver, nos

---
http://beh.santepubliquefrance.fr/beh/2023/15-16/2023_15-16_4.html
2023
France
journal article
resulting in
hospital, nos
gastroenterologist
Gastroenterologists
health
hepatitis C
association
viral hepatitis c
hospitals, general
liver, nos
Hepatitis

---
https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2023-49/numero-7-8-juillet-aout-2023/eclosion-infections-salmonella-typhimurium-liees-tofu.html
2023
Canada
journal article
salmonella typhimurium
soy foods
salmonellosis, nos (except human typhoid & paratyphoid)
ontario
salmonella infections
tofu
due to
eating, nos
Infectious disease
eating
salmonella typhimurium
Infections
canada

---
https://www.cochrane.org/fr/CD011585/LIVER_la-rifaximine-pour-la-prevention-et-le-traitement-de-lencephalopathie-hepatique-chez-les-personnes
2023
United Kingdom
review of literature
french abstract
preventive treatment, nos
disease of liver, nos
disease
hepatic encephalopathy
persons
cirrhosis of liver, nos
Encephalopathy
Rifaximin
Cirrhosis
hepatic encephalopathy
liver cirrhosis

---
https://www.has-sante.fr/jcms/p_3458293/fr/enhertu-trastuzumab-deruxtecan-cancer-de-l-estomac
2023
false
false
false
France
stomach neoplasms
adenocarcinoma
adult
treatment outcome
insurance, health, reimbursement
Locally Advanced Gastroesophageal Junction Adenocarcinoma
Refractory Gastroesophageal Junction Adenocarcinoma
Refractory Gastric Adenocarcinoma
Advanced Gastric Adenocarcinoma
Antineoplastic Agents, Immunological
trastuzumab deruxtecan
evaluation of the transparency committee
trastuzumab deruxtecan

---
https://ansm.sante.fr/informations-de-securite/ketamine-une-utilisation-prolongee-entraine-des-atteintes-graves-hepatiques-et-uronephrologiques
2023
false
false
false
France
French
pharmacovigilance note
ketamine
kidney diseases
Drug-Induced Liver Disease
cystitis
narcotics
prescription drug misuse
guidelines for drug use
Long-Term
Off-Label use
biliary tract diseases

---
https://www.has-sante.fr/jcms/p_3456351/fr/actualisation-des-recommandations-et-obligations-vaccinales-des-professionnels
2023
France
public health guidelines
measles
chickenpox
mumps
Hepatitis
pertussis
hepatitis
Whooping cough
Mumps
whooping cough
directive counseling
measles
Rubella
hepatitis, nos
influenza, human
rubella
mumps
Influenza
Measles
mumps, nos
Varicella
varicella, nos
measles
rubella, nos
rubella
chickenpox
influenza
influenza, nos
whooping cough

---
https://ansm.sante.fr/tableau-acces-derogatoire/enhertu-100-mg-poudre-pour-solution-a-diluer-pour-perfusion
2023
false
false
false
France
French
summary of product characteristics
package leaflet
guidelines for drug use
Metastatic Gastric Adenocarcinoma
stomach neoplasms
adenocarcinoma
neoplasm metastasis
Locally Advanced Gastric Adenocarcinoma
Metastatic Gastroesophageal Junction Adenocarcinoma
Locally Advanced Gastroesophageal Junction Adenocarcinoma
HER2/Neu Positive
trastuzumab deruxtecan
infusions, intravenous
trastuzumab deruxtecan
Antineoplastic Agents, Immunological
breast neoplasms
Metastatic HER2-Positive Breast Carcinoma
Unresectable HER2-Positive Breast Carcinoma
Refractory HER2-Positive Breast Carcinoma
HER2-Low Breast Carcinoma
Metastatic HER2-Low Breast Carcinoma
neoplasm recurrence, local

---
https://ansm.sante.fr/tableau-acces-derogatoire/imfinzi-50-mg-ml-solution-a-diluer-pour-perfusion
2023
false
false
false
France
French
summary of product characteristics
package leaflet
durvalumab
guidelines for drug use
Unresectable Biliary Tract Carcinoma
antineoplastic combined chemotherapy protocols
Metastatic Biliary Tract Carcinoma
durvalumab
adult
Cisplatin/Durvalumab/Gemcitabine Regimen
infusions, intravenous
cisplatin
carcinoma, hepatocellular

---
https://ansm.sante.fr/tableau-acces-derogatoire/lynparza-100-mg-et-150-mg-comprimes-pellicules
2023
false
false
false
France
French
drug information
olaparib
administration, oral
olaparib
breast neoplasms
HER2-Negative Breast Carcinoma

---
https://ansm.sante.fr/actualites/amoxicilline-des-recommandations-pour-contribuer-a-garantir-la-couverture-des-besoins-des-patients
2023
false
false
false
France
French
amoxicillin
guidelines for drug use
amoxicillin
administration, oral
infant
child
amoxicillin
amoxicillin-potassium clavulanate combination
amoxicillin-potassium clavulanate combination
amoxicillin and beta-lactamase inhibitor

---
https://www.has-sante.fr/jcms/p_3400605/fr/pantera-lux
2023
false
false
false
France
health technology assessment
tympanites
paclitaxel
flatulence
paclitaxel

---
https://www.has-sante.fr/jcms/p_3402381/fr/humira-adalimumab-maladie-de-crohn-chez-les-adolescents-et-enfants-6-ans
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
adalimumab
injections, subcutaneous
evaluation of the transparency committee
crohn disease
Adalimumab
child
adolescent

---
https://www.santepubliquefrance.fr/les-actualites/2023/hepatite-a-en-france-les-chiffres-cles-2021
2023
France
scientific and technical information
hepatitis
France
Hepatitis
france
France
France
France
french
hepatitis, nos

---
https://www.cochrane.org/fr/CD013386/GUT_ajout-dun-anneau-gastrique-fundoplicature-autour-du-tube-alimentaire-oesophage-dans-le-cadre-dune
2023
United Kingdom
review of literature
french abstract
Esophagus
stomach, nos
ring
tube, nos
Achalasia
fundoplication
esophagus
Surgery
laparoscopy
esophagospasm
achalasia, nos
laparoscopes
laparoscopy, nos
operative procedure, nos
laparoscope
stomach
fundoplication
Esophagus

---
https://www.ema.europa.eu/en/medicines/human/EPAR/livmarli
2023
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
Maralixibat Chloride
Maralixibat Chloride
maralixibat chloride
maralixibat
maralixibat
infant
child
alagille syndrome
pruritus
Cholestatic pruritus (disorder)
orphan drug production
pharmaceutical solutions
administration, oral
ileal sodium-dependent bile acid transporter
product surveillance, postmarketing
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
cholestatic pruritus in Alagille syndrome

---
https://ansm.sante.fr/actualites/decision-du-17-01-2023-renouvellement-du-cpc-de-remicade-100-mg-poudre-pour-solution-a-diluer-pour-perfusion-et-des-specialites-identifiees-comme-biologiques-similaires
https://ansm.sante.fr/tableau-acces-derogatoire/remicade-et-lensemble-des-specialites-biologiques-similaires-dinfliximab
2023
false
false
false
France
French
legislation
Infliximab
takayasu arteritis

---
https://www.ceredih.fr/uploads/CEREDIH_RECO_ANTIBIO_2022_12_16.pdf
2023
France
scientific and technical information
amoxicillin-potassium clavulanate combination
Cefpodoxime
cefpodoxime
has patient
immunologic deficiency syndromes
France
bactrim
cefpodoxime
clamoxyl
France
France
patients
disease
clavulanic acid
france
augmentin
research report
french
albumin/globulin ratio
Cefpodoxime Proxetil
tension
France
amoxycillin with clavulanate potassium
Primary Immunodeficiency Diseases
amoxicillin
primary immune deficiency disorder, nos

---
https://www.anses.fr/fr/content/eviter-intoxications-alimentaires-norovirus
2023
France
popular works
food poisoning
norovirus
foodborne diseases
Food poisoning
food poisoning, nos

---
https://www.has-sante.fr/jcms/p_3406124/fr/tecentriq-atezolizumab-cancer-bronchique-non-a-petites-cellules-cbnpc
2023
false
false
false
France
evaluation of the transparency committee
Tecentriq
neoplasm, malignant
"u" lymphocyte
cancer
atezolizumab
due to
Cancer
atezolizumab
bronchus, nos
Cell
carcinoma, non-small-cell lung
cells

---
https://kce.fgov.be/fr/publications/tous-les-rapports/prevention-du-syndrome-post-soins-intensifs-pics
2023
Belgium
technical report
french abstract
PICA syndrome
PICA syndrome
bard-pic syndrome
critical care
postintensive care syndrome
postintensive care syndrome

---
https://cms.cmq.org/files/documents/Pratique-medicale/p-1-2023-02-03-fr-groupe-travail-exigences-minimales-formation-endoscopie-digestive.pdf
2023
false
false
false
France
technical report
digestive tract function, nos
work
endoscopy, digestive system
Labor ; manpower ; population
Endoscopy
digestant, nos
occupation, nos
albumin/globulin ratio
research report
endoscopy, nos
advisory committees

---
https://www.has-sante.fr/jcms/p_3409198/fr/hexyon-vaccin-diphterique-d-tetanique-t-coque-lucheux-acellulaire-multicompose-ca-de-l-hepatite-b-adnr-hepb-poliomyelitique-inactive-p-et-de-l-haemophilus-influenzae-type-b-hib-conjugue-adsorbe
2023
false
false
false
France
evaluation of the transparency committee

---
https://www.has-sante.fr/jcms/p_3410031/fr/nifexine-nifedipine/lidocaine-chlorhydrate-douleurs-associees-a-la-fissure-anale-chronique
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
drug combinations
administration, rectal
nifedipine
lidocaine
lidocaine hydrochloride
ointments
adult
other preparations, combinations
chronic disease
Chronic anal fissure (disorder)
evaluation of the transparency committee
fissure in ano
pain

---
https://www.has-sante.fr/jcms/p_3409213/fr/glucose-30-lavoisier-glucose-monohydrate-solute
2023
false
false
false
France
insurance, health, reimbursement
-
carbohydrates
glucose solution, hypertonic
evaluation of the transparency committee
glucose
Glucose Monohydrate

---
https://www.has-sante.fr/jcms/p_3411344/fr/lynparza-olaparib-cancer-du-sein-precoce-a-haut-risque-her2-negatif
2023
false
false
false
France
Early Stage HER2-Negative Breast Carcinoma
HER2/Neu Negative
High Risk Breast Carcinoma
breast neoplasms
mutation
treatment outcome
insurance, health, reimbursement
Germline BRCA1 Gene Mutation
Germline BRCA2 Gene Mutation
administration, oral
olaparib
evaluation of the transparency committee
olaparib
breast neoplasms
risk

---
http://medecinetropicale.free.fr/cours/maladie_rat.pdf
2023
France
educational course
Disease
Diseases
splenic diseases
splenic disorder, nos

---
https://www.has-sante.fr/jcms/p_3215918/fr/indications-de-l-echographie-de-contraste-lors-de-suspicion-de-tumeur-hepatique-benigne-chez-l-adulte-sans-cirrhose-ni-cancer
2023
France
health technology assessment
Adult
Tumors
Tumors
adult
Tumors
liver cirrhosis
benign neoplasm of liver, nos
carcinoma, hepatocellular
Benin
suggestive of
Cancer
Tumors
ultrasonography
Tumors
Tumors
indicators and reagents
Adult
neoplasm, malignant
indication of
Tumors
benign neoplasms
cirrhosis of liver, nos
liver neoplasms
Tumors
Tumors
ultrasonography, nos
Tumors
Cirrhosis
Tumors
cancer of liver
adulthood
Tumors
Benign neoplasm

---
https://www.has-sante.fr/jcms/p_3400568/fr/sequent-please-neo
2023
France
health technology assessment
flatulence
paclitaxel
paclitaxel
tympanites

---
https://www.academie-medecine.fr/le-foie-steatosique-non-alcoolique-un-defi-de-sante-publique/
2023
France
technical report
Alcoholism
public health
Non-alcoholic Fatty Liver Disease
Public health
Alcoholism
Alcoholism
nonalcoholic fatty liver

---
https://www.has-sante.fr/jcms/p_3417216/fr/lutonix-035
2023
France
health technology assessment
flatulence
paclitaxel
paclitaxel
tympanites

---
https://www.has-sante.fr/jcms/p_3417219/fr/ranger
2023
France
health technology assessment
paclitaxel
tympanites
flatulence
paclitaxel

---
https://www.has-sante.fr/jcms/p_3395770/fr/keytruda-pembrolizumab-melanome-de-stade-iib-iic-ou-iii
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
adult
adolescent
Stage IIB Cutaneous Melanoma AJCC v6 and v7
Stage IIC Cutaneous Melanoma AJCC v6 and v7
melanoma
Stage III Cutaneous Melanoma AJCC v7
Advanced Cutaneous Melanoma
infusions, intravenous
Antineoplastic Agents, Immunological
evaluation of the transparency committee
melanoma
pembrolizumab

---
https://ansm.sante.fr/tableau-atu-rtu/opdivo-nivolumab-solution-a-diluer-pour-perfusion-yervoy-ipilimumab-solution-a-diluer-pour-perfusion
2023
false
false
false
France
French
guidelines for drug use
Nivolumab
Ipilimumab/Nivolumab Regimen
Ipilimumab
Antineoplastic Agents, Immunological
Malignant Pleural Mesothelioma
disease progression
Progressive Neoplastic Disease
infusions, intravenous
continuity of patient care
drug monitoring
carcinoma, non-small-cell lung
melanoma
Stage IIB Cutaneous Melanoma AJCC v6 and v7
Stage IIIB Cutaneous Melanoma AJCC v7

---
https://www.snfge.org/tncd/neoplasies-neuroendocrines-digestives
2023
false
false
false
France
neuroendocrine tumors
digestive system neoplasms
Digestive System Neuroendocrine Neoplasm
Digestive System Neuroendocrine Neoplasm
Digestive System Neuroendocrine Neoplasm
continuity of patient care
Digestive System Neuroendocrine Neoplasm
neoplasm metastasis
Digestive System Neuroendocrine Neoplasm
Digestive System Neuroendocrine Neoplasm
Peritoneal Carcinomatosis
bone neoplasms
practice guideline

---
https://www.snfge.org/tncd/cancer-du-rectum
2023
false
false
France
French
endosonography
digestive system surgical procedures
radiotherapy
neoplasm metastasis
rectal neoplasms
france
incidence
rectal neoplasms
rectal neoplasms
rectal neoplasms
proctoscopy
rectal neoplasms
rectal neoplasms
prognosis
rectal neoplasms
rectal neoplasms
continuity of patient care
neoplasm recurrence, local
practice guideline
rectal neoplasms

---
http://www.palliaguide.be/diarrhees-soins-palliatifs/
2023
false
false
false
Belgium
French
practice guideline
palliative care
diarrhea
diarrhea
diarrhea
diarrhea

---
https://www.snfcp.org/wp-content/uploads/2019/02/Informations-avant-la-re%CC%81alisation-dune-he%CC%81morroi%CC%88dectomie.pdf
2023
false
false
false
France
patient education handout
hemorrhoidectomy
hemorrhoidectomy, nos

---
https://ansm.sante.fr/tableau-marr/lutecium-177lu-oxodotreotide
2023
false
false
false
France
French
lutetium Lu 177 dotatate
risk management
patients guideline
lutetium Lu 177 dotatate
infusions, intravenous
radiotherapy
radiopharmaceuticals
radiopharmaceuticals
neuroendocrine tumors
lutetium (177Lu) oxodotreotide
drug information
organometallic compounds
octreotide
octreotide
organometallic compounds
octreotide

---
https://www.has-sante.fr/jcms/p_3460573/fr/kaftrio-ivacaftor-/-tezacaftor-/-elexacafto-en-association-avec-kalydeco-mucoviscidose-enfant-6-ans
2023
false
false
false
France
insurance, health, reimbursement
treatment outcome
drug therapy, combination
drug combinations
elexacaftor, ivacaftor, tezacaftor drug combination
elexacaftor
ivacaftor
tezacaftor
guidelines for drug use
evaluation of the transparency committee
child
cystic fibrosis

---
https://www.has-sante.fr/jcms/p_3459834/fr/imfinzi-/-tremelimumab-astrazeneca-durvalumab-/-tremelimumab-cancer-bronchique-non-a-petites-cellules-cbnpc
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
platinum compounds
antineoplastic combined chemotherapy protocols
Antineoplastic Agents, Immunological
bronchial neoplasms
neoplasm metastasis
Metastatic Lung Non-Small Cell Carcinoma
Activating EGFR Gene Mutation Negative
Activating ALK Gene Mutation Negative
Durvalumab/Tremelimumab Regimen
evaluation of the transparency committee
tremelimumab
carcinoma, non-small-cell lung
durvalumab

---
https://www.has-sante.fr/jcms/p_3460521/fr/opdivo-nivolumab-cancer-bronchique-cbnpc
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
guidelines for drug use
nivolumab
infusions, intravenous
Antineoplastic Agents, Immunological
bronchial neoplasms
programmed cell death 1 receptor
antineoplastic combined chemotherapy protocols
PD-L1 Expression Greater than or Equal to 1 Percent
neoadjuvant therapy
adult
platinum compounds
Sensitizing EGFR Mutation Negative
ALK Gene Translocation Negative
evaluation of the transparency committee
Nivolumab
carcinoma, non-small-cell lung

---
https://dumas.ccsd.cnrs.fr/dumas-04191396
2023
France
dissertations, academic
constipation
Have Constipation
constipation
Usual Severity Constipation
constipation
Constipation, CTCAE
How Much Distress Constipation
Alternator Device
How Often Constipation
self medication
Constipation

---
https://sante.gouv.fr/IMG/pdf/dgs-urgent_2023-15_-_intoxication_alimentaire_grave_-_plusieurs_cas_de_botulisme.pdf
2023
France
scientific and technical information
foodborne botulism
True Case Status
Repository
botulism
Catenin Delta-1
Packaging Case
Serious
botulism
food poisoning
food poisoning, nos
Case
restaurants
BCAR1 wt Allele
Breast Cancer Anti-Estrogen Resistance Protein 1
snacks
Coronavirus Anxiety Scale
No Cases Transmission Pattern
Foodborne Illness
Case Dosing Unit
CTNND1 wt Allele
severe
Botulism

---
https://www.snfge.org/actualites/aucune-utilite-clinique-tests-sanguins-depistage-dune-allergie-alimentaire-dosage
2023
false
false
false
France
popular works
Blood Screening
immunoglobulin measurement, nos
IgG
Clinical Data
immunoglobulin igg, nos
immunoglobulins
hospitals, proprietary
food, nos
Ambulatory Care Facility
screening
allergy testing, nos
Useful
Food
gastrointestinal food allergy, nos
Immunoglobulin Measurement
Hematology Test
Clinical Batch
With Food
mass screening
eating, nos
Clinical Lot
immunoglobulin G
food
food hypersensitivity
Food Allergy

---
https://www.has-sante.fr/jcms/p_3460613/fr/movicol-macrogol-3350-potassium-chlorure-sodium-bicarbonate-et-chlorure-laxatif-iso-osmotique
2023
false
false
false
France
insurance, health, reimbursement
macrogol, combinations
laxatives
constipation
fecal impaction
drug combinations
evaluation of the transparency committee
sodium chloride
polyethylene glycol 3350
polyethylene glycols
potassium chloride
sodium bicarbonate

---
https://www.has-sante.fr/jcms/p_3463328/fr/passeo-18-lux
2023
France
health technology assessment
paclitaxel
tympanites
paclitaxel
flatulence
Luxembourg
Paclitaxel
Balloon Device
Pegylated Paclitaxel

---
https://ansm.sante.fr/informations-de-securite/simponi-golimumab-50-mg-et-100-mg-modifications-importantes-des-instructions-dutilisation-du-stylo-prerempli-smartject
2023
false
false
false
France
French
guidelines for drug use
golimumab
pharmacovigilance note
Pre-filled Pen Syringe
injections, subcutaneous
Device malfunction

---
https://ansm.sante.fr/actualites/campagne-de-vaccination-contre-les-virus-hpv-lansm-deploie-un-dispositif-de-surveillance-renforcee
2023
false
false
false
France
French
drug information
mass vaccination
papillomavirus vaccines
france
papillomavirus infections
pharmacovigilance
product surveillance, postmarketing
papillomavirus vaccines

---
https://www.cochrane.org/fr/CD012358/LIVER_quels-sont-les-benefices-et-les-risques-des-stents-recouverts-par-rapport-aux-stents-nus
2023
United Kingdom
review of literature
french abstract
Intrahepatic Route of Administration
risks and benefits
cirrhosis of liver, nos
persons
albumin/globulin ratio
Macau
What Month is it
systemic administration
Cirrhosis
Shunt
Systemic Immunotherapy
People
liver cirrhosis
research report
Recovered from Adverse Event
risk assessment
Shunt Device
stents
Stent Device
Hazard Ratio
disease
shunt, nos

---
Summary Safety Review - Keytruda (pembrolizumab) and Tecentriq (atezolizumab) - Assessing the Potential Risk of Aplastic Anemia
https://pmps.hpfb-dgpsa.ca/documents-d-examen/ressource/SSR1691503886633
2023
false
false
false
Canada
French
drug evaluation
Drug-Related side effects and adverse reactions
pembrolizumab
antibodies, monoclonal, humanized
atezolizumab
Antineoplastic Agents, Immunological
risk assessment
anemia, aplastic
Immune Checkpoint Inhibitors
canada
pharmacovigilance note

---
https://www.minerva-ebp.be/FR/Article/2343
2023
Belgium
critical appraisal or critical reading
Cognitive Decline
Declining
Cognitive
Relationship
eating, nos
Israel
Food, Ultra-Processed
With Food
eating
Food
consumer organizations
cognition, nos
Illinois
cognition
Interleukin
What Month is it
food, nos

---
https://www.has-sante.fr/jcms/p_3467526/fr/tibsovo-ivosidenib-leucemie-aigue-myeloide-lam
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
administration, oral
antineoplastic agents
ivosidenib
antineoplastic combined chemotherapy protocols
adult
IDH1 NP_005887.2:p.R132X
acute myeloid leukaemia with an IDH1 R132 mutation
Azacitidine/Ivosidenib Regimen
azacitidine
evaluation of the transparency committee
ivosidenib
leukemia, myeloid, acute

---
https://www.cochrane.org/fr/CD014685/LIVER_les-machines-perfusion-peuvent-elles-ameliorer-la-qualite-des-foies-donnes-pour-la-transplantation
2023
United Kingdom
review of literature
french abstract
Improved
Data Accuracy
Machinery Heart Murmur
machine, nos
Graft
liver transplantation
research design
Chemotherapeutic Perfusion
perfusion
transplantation of liver, nos
quality improvement
Infusion Procedure
transplantation
What Month is it
Transplantation
Data Quality
Perfusion
perfusion of liver
Enhance
Infusion Method of Administration

---
https://www.has-sante.fr/jcms/p_3470456/fr/orkambi-lumacaftor/ivacaftor-mucoviscidose-enfant
2023
false
false
false
France
lumacaftor, ivacaftor drug combination
treatment outcome
insurance, health, reimbursement
ivacaftor
lumacaftor
drug combinations
administration, oral
ivacaftor and lumacaftor
Chloride Channel Agonists
cystic fibrosis
CFTR delta F508
guidelines for drug use
evaluation of the transparency committee
infant
cystic fibrosis

---
https://www.has-sante.fr/jcms/p_3468042/fr/telebrix-gastro-ioxitalamate-demeglumine-produit-de-contraste-iode-pour-les-explorations-radiologiques-du-tube-digestif
2023
false
false
false
France
insurance, health, reimbursement
gastrointestinal tract
evaluation of the transparency committee
meglumine ioxithalamate
contrast media

---
https://www.has-sante.fr/jcms/p_3468039/fr/micropaque-scanner-sulfate-de-baryum-produit-de-contraste-baryte-pour-les-explorations-scanographiques-du-tube-digestif
2023
false
false
false
France
insurance, health, reimbursement
gastrointestinal tract
tomography, X-ray computed
contrast media
barium sulfate
evaluation of the transparency committee

---
https://www.has-sante.fr/jcms/p_3471682/fr/opdivo-nivolumab-cbnpc-cancer-bronchique-non-a-petites-cellules
2023
false
false
false
France
bronchial neoplasms
treatment outcome
insurance, health, reimbursement
Antineoplastic Agents, Immunological
nivolumab
antineoplastic combined chemotherapy protocols
platinum compounds
neoadjuvant therapy
resectable non-small cell lung cancer at high risk of recurrence in patients whose tumours have PD-L1 expression ≥ 1%
evaluation of the transparency committee
Nivolumab
carcinoma, non-small-cell lung

---
https://www.cochrane.org/fr/CD011806/GUT_la-vitamine-d-dans-le-traitement-des-maladies-inflammatoires-de-lintestin
2023
United Kingdom
review of literature
french abstract
Treatment
No Treatment for Diabetes
inflammatory bowel disease, nos
Treatment Epoch
inflammatory bowel diseases
Gastrointestinal Tract
On Treatment
Intestinal
Biomaterial Treatment
Vitamin D Measurement
Treat
vitamin D
Bowel Continence
Treatment Study
vitamin d, nos
Inflammatory Disorder
Intestine
During Treatment
Murine Intestines
Gastric Intestinal-Type Adenocarcinoma
GDC Treatment Frequency Terminology
Therapy Object
Ergocalciferol

---
https://dumas.ccsd.cnrs.fr/dumas-04258771v1
2023
France
dissertations, academic
Source Data Not Available
databases as topic
Rare Disorder
digestive tract function, nos
database
disease, nos
digestants
digestive system diseases
digestant, nos
digestion
rare diseases
Creation
Digestion
Long Interspersed Element
Ligne
Clinical Trial Source Data
base, nos
Creation
Database
Line Unit of Length

---
https://dumas.ccsd.cnrs.fr/dumas-04260850
2023
France
dissertations, academic
Delphi Process
research
Evolution
symptom, nos
Palliative Medicine
digestants
Research Methods
delphi technique
palliative care
managed care programs
digestant, nos
gastrointestinal agents
general practitioners
Hospice Care
Digestion
General Qualifier
consensus
tool, nos
Search Engine
palliative care, nos
digestive tract function, nos
syndrome

---
https://www.fimatho.fr/images/2021/Documents_pages/FIMATHO_32p_oesophage_MAJ_2021_HD.pdf
2023
France
patient education handout
Esophageal Atresia
esophageal atresia
congenital atresia of esophagus

---
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-hpv
2023
false
false
false
France
French
drug information
product surveillance, postmarketing
pharmacovigilance
Vaccination Campaign
vaccination
papillomavirus vaccines
adolescent
drug monitoring
Human Papillomavirus Recombinant Vaccine nonavalent
papillomavirus (human types 6, 11, 16, 18, 31, 33, 45, 52,58)

---
https://www.has-sante.fr/jcms/p_3477470/fr/restore-deb
2023
France
health technology assessment
Pet is as Active as it Has Been
Paclitaxel
Balloon Device
Active Control
Release Determination
Diepoxybutane
flatulence
Patient Discharge
Pegylated Paclitaxel
Active State
paclitaxel
Release
Active License
tympanites
paclitaxel

---
https://www.sfed.org/wp-content/uploads/2023/05/ph-METRIE-303.pdf
2023
France
patient education handout
Oprelvekin
achievement
esophageal pH monitoring
acoustic impedance tests
Informed
Informative
No Information Available
Esophageal

---
https://www.has-sante.fr/jcms/p_3479047/fr/rinvoq-upadacitinib-maladie-de-crohn-active-moderee-a-severe-chez-les-patients-adultes
2023
false
false
false
France
treatment outcome
Delayed-Action preparations
upadacitinib
Janus Kinase Inhibitors
insurance, health, reimbursement
evaluation of the transparency committee
crohn disease
adult
upadacitinib

---
https://www.has-sante.fr/jcms/p_3478087/fr/opdivo-yervoy-ipilimumab/nivolumab-cancer-de-l-oesophage
2023
France
evaluation of the transparency committee
Nivolumab
esophageal neoplasms
Ipilimumab
yervoy
esophagospasm
cancer of esophagus
Childhood Esophageal Carcinoma
neoplasm, malignant
Opdivo

---
https://www.has-sante.fr/jcms/p_3482424/fr/tibsovo-ivosidenib-cancer-voies-biliaires
2023
false
false
false
France
adult
treatment outcome
insurance, health, reimbursement
antineoplastic agents
administration, oral
Advanced Cholangiocarcinoma
Unresectable Cholangiocarcinoma
Metastatic Cholangiocarcinoma
evaluation of the transparency committee
biliary tract cancer
biliary tract neoplasms
ivosidenib

---
https://www.sfed.org/wp-content/uploads/2024/01/Recommandations-sur-les-criteres-de-qualite-en-endoscopie-digestive.pdf
2023
France
guideline
digestive tract function, nos
Endoscopic Procedure
endoscopy, nos
health planning guidelines
Criterion
digestant, nos
endoscopy, digestive system
Digestion

---
https://dumas.ccsd.cnrs.fr/dumas-04394005
2023
France
dissertations, academic
dermatology
intestinal diseases
Pathology
microbiota
Intestinal Flora
Gastrointestinal Microbiome
Dermatologists
intestines
intestinal tract, nos
counseling
Dermatologist
Integumentary System Finding
Transjugular Intrahepatic Portosystemic Shunt
Diseased

---
https://www.medix.ch/fr/connaissances/guide-des-bonnes-pratiques/dyspepsie-fonctionnelle/
2023
Switzerland
practice guideline
Dyspepsia
dyspepsia, nos
dyspepsia

---
https://www.medix.ch/fr/connaissances/guide-des-bonnes-pratiques/proctologie/
2023
Switzerland
practice guideline
colorectal surgery
proctology

---
https://www.snfcp.org/wp-content/uploads/2023/02/Informations-avant-la-re%CC%81alisation-dune-cure-chirurgicale-de-prolapsus-rectal-exte%CC%81riorise-selon-Altemeier.pdf
2023
France
patient education handout
rectal prolapse
rectal prolapse
Continuing Umbrella of Research Experience for Underserved Minorities (CURE) Program
Rectal Prolapse
achievement
Tiaprofenic Acid
Oprelvekin
Informative
Expedited Report
exteriorization
Cure Study
Informed
No Information Available

---
https://dumas.ccsd.cnrs.fr/dumas-04448648
2023
France
dissertations, academic
Biomedicine
patient care management
general practice
Food Allergy
eating
food hypersensitivity
Charge
Family Practice
gastrointestinal food allergy, nos

---
https://www.has-sante.fr/jcms/p_3418058/fr/imjudo-tremelimumab-carcinome-hepato-cellulaire
2023
false
false
false
France
insurance, health, reimbursement
treatment outcome
tremelimumab
antineoplastic agents
antineoplastic combined chemotherapy protocols
durvalumab
adult
Advanced Hepatocellular Carcinoma
Unresectable Hepatocellular Carcinoma
Child-Pugh Class A
ECOG Performance Status 0
ECOG Performance Status 1
Durvalumab/Tremelimumab Regimen
evaluation of the transparency committee
carcinoma, hepatocellular
tremelimumab

---
https://www.has-sante.fr/jcms/p_3418145/fr/livmarli-maralixibat-syndrome-d-alagille
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
maralixibat chloride
infant
child
Cholestatic pruritus (disorder)
administration, oral
orphan drug production
evaluation of the transparency committee
maralixibat
alagille syndrome

---
https://www.has-sante.fr/jcms/p_3418037/fr/imfinzi-durvalumab-carcinome-hepato-cellulaire
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
antineoplastic combined chemotherapy protocols
tremelimumab
durvalumab
adult
Advanced Adult Hepatocellular Carcinoma
Unresectable Hepatocellular Carcinoma
Child-Pugh Class A
ECOG Performance Status 0
ECOG Performance Status 1
infusions, intravenous
evaluation of the transparency committee
durvalumab
carcinoma, hepatocellular

---
https://www.has-sante.fr/jcms/p_3417971/fr/opdivo-nivolumab-adenocarcinome-gastrique
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
antineoplastic combined chemotherapy protocols
Advanced Gastric Adenocarcinoma
Metastatic Gastric Adenocarcinoma
Metastatic Gastroesophageal Junction Adenocarcinoma
Advanced Gastroesophageal Junction Adenocarcinoma
adenocarcinoma of esophagus
esophageal neoplasms
Advanced Esophageal Adenocarcinoma
Metastatic Esophageal Adenocarcinoma
HER2/Neu Negative
PD-L1 Positive
infusions, intravenous
nivolumab
evaluation of the transparency committee
adenocarcinoma
Nivolumab
stomach neoplasms

---
https://www.cochrane.org/fr/CD013328/INFECTN_interventions-visant-ameliorer-lassainissement-pour-prevenir-la-diarrhee
2023
United Kingdom
review of literature
french abstract
sanitation
diarrhea
diarrhea, nos
diarrhoea
Diarrhea
attentiveness

---
https://www.has-sante.fr/jcms/p_3420695/fr/lenvima-lenvatinib-cancer-de-l-endometre
2023
false
false
false
France
antineoplastic agents
protein kinase inhibitors
lenvatinib
antineoplastic combined chemotherapy protocols
pembrolizumab
Lenvatinib/Pembrolizumab Regimen
adult
Advanced Endometrial Carcinoma
Recurrent Endometrial Carcinoma
Refractory Endometrial Carcinoma
Unresectable Endometrial Carcinoma
administration, oral
evaluation of the transparency committee
lenvatinib
endometrial neoplasms

---
https://www.cochrane.org/fr/CD011507/PREG_la-prise-de-myo-inositol-comme-supplement-alimentaire-pendant-la-grossesse-pour-prevenir-le
2023
United Kingdom
review of literature
french abstract
pregnancy
inositol
dietary supplements
inositol
eating
attentiveness
Gestational diabetes
diabetes, gestational
pregnancy, nos

---
https://www.has-sante.fr/jcms/p_3422332/fr/jakavi-ruxolitinib-maladie-du-greffon
2023
false
false
false
France
insurance, health, reimbursement
treatment outcome
adolescent
graft vs host disease
acute disease
chronic disease
Steroid Refractory Graft Versus Host Disease
ruxolitinib
drug resistance
Chronic Graft Versus Host Disease
Acute Graft Versus Host Disease
administration, oral
evaluation of the transparency committee
ruxolitinib

---
https://ansm.sante.fr/tableau-acces-derogatoire/jakavi-5-mg-comprime
2023
false
false
false
France
French
insurance, health, reimbursement
ruxolitinib phosphate
ruxolitinib
administration, oral
drug information
graft vs host disease
drug resistance
Steroid Refractory Graft Versus Host Disease
acute disease
chronic disease

---
https://ansm.sante.fr/tableau-marr/upadacitinib
2023
false
false
false
France
French
risk management
upadacitinib
patient education handout
guidelines for drug use
upadacitinib
Drug-Related side effects and adverse reactions
administration, oral
upadacitinib
Janus Kinase Inhibitors
Janus Kinase Inhibitors
teratogens
pregnancy
continuity of patient care
herpes zoster
tuberculosis
neoplasms
embolism and thrombosis
Virus Reactivation

---
https://www.has-sante.fr/jcms/p_3424347/fr/enhertu-trastuzumab-deruxtecan-cancer-du-sein-her2
2023
false
false
false
France
Metastatic HER2-Positive Breast Carcinoma
Refractory HER2-Positive Breast Carcinoma
Unresectable HER2-Positive Breast Carcinoma
Antineoplastic Agents, Immunological
receptor, erbB-2
treatment outcome
insurance, health, reimbursement
adult
trastuzumab deruxtecan
infusions, intravenous
evaluation of the transparency committee
breast neoplasms
Trastuzumab
trastuzumab deruxtecan

---
https://www.has-sante.fr/jcms/p_3421134/fr/livmarli-maralixibat-syndrome-d-alagille-sag
2023
false
false
false
France
French
evaluation of the transparency committee
treatment outcome
insurance, health, reimbursement
maralixibat
alagille syndrome
Maralixibat Chloride
maralixibat chloride
infant
child
administration, oral
Cholestatic pruritus (disorder)
pruritus
pharmaceutical solutions
cholestatic pruritus in Alagille syndrome

---
Imjudo - tremelimumab
https://www.ema.europa.eu/en/medicines/human/EPAR/imjudo
2023
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
tremelimumab
tremelimumab
orphan drug production
drug approval
europe
tremelimumab
antineoplastic agents
antineoplastic agents
carcinoma, hepatocellular
Unresectable Hepatocellular Carcinoma
Advanced Hepatocellular Carcinoma
antineoplastic combined chemotherapy protocols
durvalumab
Durvalumab/Tremelimumab Regimen
infusions, intravenous
CTLA4 protein, human
product surveillance, postmarketing
drug interactions
pregnancy
breast feeding
Female of Childbearing Potential
drug evaluation, preclinical

---
https://www.has-sante.fr/jcms/p_3425643/fr/lynparza-olaparib-cancer-de-la-prostate
2023
false
false
false
France
antineoplastic combined chemotherapy protocols
treatment outcome
insurance, health, reimbursement
abiraterone
prednisone
prednisolone
neoplasm metastasis
adult
metastatic castration resistant prostate cancer
olaparib
antineoplastic agents
guidelines for drug use
administration, oral
evaluation of the transparency committee
olaparib
prostatic neoplasms

---
https://www.has-sante.fr/jcms/p_3426145/fr/humira-adalimumab-psoriasis-en-plaques-chez-l-enfant-et-adolescent
2023
France
evaluation of the transparency committee
Adalimumab
adalimumab
Adolescent
adolescence
Psoriasis
Adolescent
child
Child
psoriasis vulgaris
Child
psoriasis
Child
Child
bone plates
humira
child, nos
adolescent

---
https://www.maisonmedicale.org/sante-conjuguee/manger-autrement-par-choix-ou-par-contrainte/
2023
Belgium
journal article
choice behavior
stress, physiological
eating, nos
eating

---
https://www.euro-pharmat.com/les-publications/download/7769/5881/254
2023
France
journal article
equipment and supplies
Techniques
Techniques
health planning guidelines
Techniques
gastrostomy, nos
Techniques
medical devices
device, nos
choice behavior
gastrostomy
medical laboratory science

---
https://www.youtube.com/watch?v=ANcl6D2gWzg
2023
France
video recording
hepatitis D
Hepatitis
hepatitis, nos

---
https://www.srlf.org/media/place-decontamination-digestive-reanimation-2023
2023
France
sound
digestant, nos
digestants
decontamination
gastrointestinal agents
digestion
resuscitation
digestive tract function, nos

---
https://www.has-sante.fr/jcms/p_3427763/fr/bylvay-odevixibat-prurit-cholestatique-associe-au-syndrome-d-alagille
2023
false
false
false
France
cholestatic pruritus in Alagille syndrome
infant
child
guidelines for drug use
treatment outcome
insurance, health, reimbursement
administration, oral
odevixibat
evaluation of the transparency committee
pruritus
alagille syndrome
odevixibat

---
https://www.snfge.org/actualites/tutogastro-constipation-terminale-distale-comment-sen-sortir-0
2023
false
false
false
France
audiovisual aids
constipation
constipation
Constipation
end-stage
constipation

---
https://www.has-sante.fr/jcms/p_3428419/fr/teysuno-gimeracil/tegafur/oteracil-cancer-colorectal
2023
false
false
false
France
tegafur-gimeracil-oteracil
treatment outcome
insurance, health, reimbursement
adult
antineoplastic combined chemotherapy protocols
tegafur, combinations
neoplasm metastasis
antineoplastic agents
drug combinations
tegafur
gimeracil
oxonic acid
evaluation of the transparency committee
colorectal neoplasms

---
https://www.srlf.org/article/pancreatite-aigue-faible-gravite-remplissage-vasculaire-consommer-moderation
2023
France
critical appraisal or critical reading
blood vessel, nos
asthenia
acute pancreatitis
economics
gravity
gravity
gravitation
Pancreatitis
pancreatitis
temperance

---
https://dumas.ccsd.cnrs.fr/dumas-04093523
2023
France
pharmacist
patient care management
role
Eating behavior disorders
Feeding and Eating Disorders
feeding behavior
pharmacists
Eating behavior disorders
Eating behavior disorders
eating
behavior disorders
Eating behavior disorders
Eating disorder
dental behavior management, nos

---
https://www.academie-medecine.fr/enjeux-medicaux-et-societaux-de-la-transplantation-hepatique-th-en-france/
2023
France
technical report
transplantation, nos
France
France
France
France
french
liver, nos
france
liver transplantation

---
https://www.youtube.com/watch?v=aWV7Oo2LofQ
2023
false
false
false
France
audiovisual aids
ileitis, nos
Ileitis
Balance Sheet
ileitis

---
https://ansm.sante.fr/dossiers-thematiques/vaccins-contre-les-infections-a-papillomavirus-humains-hpv
2023
false
false
false
France
French
drug information
papillomavirus vaccines
papillomavirus infections
vaccine potency
papillomavirus vaccines
france
papillomavirus vaccines

---
https://www.ema.europa.eu/en/medicines/human/EPAR/tibsovo-0
2023
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
ivosidenib
ivosidenib
ivosidenib
orphan drug production
antineoplastic agents
antineoplastic agents
adult
enzyme inhibitors
enzyme inhibitors
antineoplastic combined chemotherapy protocols
Azacitidine/Ivosidenib Regimen
leukemia, myeloid, acute
IDH1 NP_005887.2:p.R132X
leukemia, myeloid, acute
IDH1 Gene Mutation
cholangiocarcinoma
Locally Advanced Cholangiocarcinoma
Metastatic Cholangiocarcinoma
cholangiocarcinoma
mutation
administration, oral
IDH1 protein, human
IDH1 inhibitor
product surveillance, postmarketing
drug interactions
fertility
pregnancy
breast feeding
drug evaluation, preclinical
acute myeloid leukaemia with an IDH1 R132 mutation
locally advanced or metastatic cholangiocarcinoma with an IDH1 R132 mutation

---
https://www.has-sante.fr/jcms/p_3444788/fr/enhertu-trastuzumab-deruxtecan-cancer-du-sein-her2-faible
2023
false
false
false
France
French
treatment outcome
insurance, health, reimbursement
evaluation of the transparency committee
trastuzumab deruxtecan
trastuzumab deruxtecan
Antineoplastic Agents, Immunological
breast neoplasms
neoplasm metastasis
Metastatic HER2-Low Breast Carcinoma
adult
Unresectable Breast Carcinoma
HER2/Neu Low Expression
infusions, intravenous

---
https://ansm.sante.fr/informations-de-securite/rucaparib-rubraca-recommandation-temporaire-de-ne-pas-initier-de-traitement-en-troisieme-ligne-therapeutique-compte-tenu-de-la-diminution-de-la-survie-globale-par-rapport-au-traitement-de-reference-analyse-intermediaire-de-letude-co-338-043-ariel4
2022
false
false
false
France
French
pharmacovigilance note
survival
rucaparib
Carcinoma, Ovarian Epithelial
fallopian tube neoplasms
peritoneal neoplasms
risk assessment
Poly(ADP-ribose) Polymerase Inhibitors
rucaparib
guidelines

---
https://www.has-sante.fr/jcms/p_3343179/fr/kaftrio-elexacaftor/-ivacaftor/-tezacaftor-mucoviscidose
2022
false
false
false
France
elexacaftor, ivacaftor, tezacaftor drug combination
ivacaftor
elexacaftor
insurance, health, reimbursement
treatment outcome
administration, oral
cystic fibrosis with F508del mutation in the cystic fibrosis transmembrane conductance regulator gene
drug combinations
ivacaftor, tezacaftor and elexacaftor
CFTR delta F508
evaluation of the transparency committee
tezacaftor
cystic fibrosis

---
https://ansm.sante.fr/informations-de-securite/ocalivav-acide-obeticholique-nouvelle-contre-indication-pour-le-traitement-de-la-cholangite-biliaire-primitive-cbp-chez-les-patients-presentant-une-cirrhose-hepatique-decompensee-ou-des-antecedents-de-decompensation-hepatique
2022
false
false
false
France
French
pharmacovigilance note
Primary Biliary Cholangitis
obeticholic acid
Hepatic decompensation
obeticholic acid
guidelines for drug use

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/utilisation-en-contexte-quebecois-des-inhibiteurs-de-la-tyrosine-kinase-du-recepteur-du-facteur-de-croissance-epidermique-egfr-pour-le-traitement-du-cancer-du-poumon.html
2022
Canada
technical report
Lung cancer
tyrosine
tyrosine
EGF Receptors
receptors, growth factor
epidermal growth factor-urogastrone receptor site
lung neoplasms
receptor Protein-Tyrosine kinases
epidermal growth factor
lung cancer
neoplasm, malignant

---
https://www.has-sante.fr/jcms/p_3343185/fr/kaftrio-elexacaftor/-ivacaftor/-tezacaftor-mucoviscidose
2022
false
false
false
France
French
evaluation of the transparency committee
tezacaftor
registries
cystic fibrosis
tezacaftor
Cystic fibrosis
cystic fibrosis

---
https://ansm.sante.fr/informations-de-securite/defitelio-defibrotide-v-a-ne-pas-utiliser-en-prophylaxie-de-la-maladie-veino-occlusive-mvo-apres-une-transplantation-de-cellules-souches-hematopoietiques-tcsh
2022
false
false
false
France
French
hematopoietic stem cell transplantation
pharmacovigilance note
defibrotide
infusions, intravenous
defibrotide
survival
hepatic veno-occlusive disease
treatment outcome
medical futility

---
https://dumas.ccsd.cnrs.fr/dumas-03684499
2022
France
dissertations, academic
patient escort service
crohn's disease, nos
pharmacist
sick role
Diseases
crohn disease
has patient
pharmacists
Disease

---
https://www.has-sante.fr/jcms/p_3343182/fr/kalydeco-ivacaftor-mucoviscidose-6-ans
2022
false
false
false
France
evaluation of the transparency committee
cystic fibrosis
Cystic fibrosis
ivacaftor
cystic fibrosis
traction
indication of
kalydeco
ivacaftor
ivacaftor
indicators
indicators and reagents

---
https://www.sfed.org/sites/www.sfed.org/files/2022-06/Coloscopie%20assistee%20a%CC%80%20l%27eau%20version%20finale%20V2.pdf
2022
France
practice guideline
colonoscopes
Water
colonoscopy
water
Bacteriology
judgment
streams
rivers
Water
bacteriology
counseling
bacteriologist

---
https://www.srlf.org/article/drainage-necrose-pancreatique-infectee-il-faut-savoir-attendre-patients-stabilises
2022
France
critical appraisal or critical reading
patients
Necrosis
necrosis of pancreas
has patient
Infectious disease
knowledge
drain, nos
drainage
necrosis
infectious disease, nos

---
https://apps.who.int/iris/bitstream/handle/10665/357786/WHO-UnkHep-Clinical-CRF-2022.1-fre.pdf
2022
Switzerland
scientific and technical information
Child
severe
Hepatitis
acute hepatitis, nos
child
Child
observation
hepatitis
child, nos
Child
Child

---
https://www.anses.fr/fr/system/files/NUT2019SA0111.pdf
2022
France
technical report
Complement
inlets
food containers
curcuma
bays
eating
curcumin
dietary supplements
risk assessment
judgment
relative risk

---
https://www.usherbrooke.ca/baladocritique/archives/episode-48-etude-poise-3
2022
Canada
sound
efficiency
safety
acid, nos
data collection
Safety
episode of
tranexamic acid

---
https://www.paediatrieschweiz.ch/fr/immunotherapie-orale-pour-le-traitement-des-allergies-alimentaires-chez-lenfant/
2022
Switzerland
journal article
food hypersensitivity
Food allergy
immunotherapy
immunotherapy, nos
Child
Child
Child
gastrointestinal food allergy, nos
Child
child, nos
Immunotherapy
child

---
https://www.paediatrieschweiz.ch/fr/oesophagite-a-eosinophiles-update-2022/
2022
Switzerland
journal article
Esophagitis
eosinophilic esophagitis
eosinophil
esophagitis, nos
Eosinophilia
eosinophilia, nos

---
https://www.anses.fr/fr/system/files/BIORISK2022SA0110.pdf
2022
false
false
false
France
Mpox (monkeypox)
public health guidelines
risk reduction
manipulation
relative risk
Viruses
eating
Virus
risk reduction behavior
health planning guidelines
monkeypox virus
Drives
virus, nos
inlets
monkeypox

---
https://ansm.sante.fr/disponibilites-des-produits-de-sante/medicaments/iobenguane-131i-pour-therapie-cis-bio-international-370-mbq-ml-solution-pour-perfusion-iobenguane-131i
2022
false
false
false
France
French
drug information
iobenguane (131i)
administration, intravenous
antineoplastic agents
radiopharmaceuticals
iobenguane (131I)

---
https://publication-theses.unistra.fr/public/theses_exercice/MED/2022/2022_DA%20SILVA_Franck.pdf
2022
France
dissertations, academic
oxytocin
alzheimer's disease, nos
microbiota
review literature as topic
digestive system diseases
oxytocin
Systematics
Disease
parturition
Systematics
alzheimer disease
Systematics
Diseases
Taxonomy
Systematic Review
Literature
neurodegenerative diseases
classification
digestion
dyspepsia, nos
digestants
birth, nos

---
https://www.has-sante.fr/jcms/p_3351104/fr/lutonix-018
2022
France
health technology assessment
paclitaxel
tympanites
flatulence
paclitaxel

---
https://www.ema.europa.eu/en/medicines/human/EPAR/hukyndra
2022
false
false
false
Netherlands
French
English
Adalimumab
Adalimumab
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
adalimumab
injections, subcutaneous
psoriasis
arthritis, psoriatic
arthritis, juvenile
hidradenitis suppurativa
crohn disease
arthritis, rheumatoid
pregnancy
breast feeding
drug interactions
spondylitis, ankylosing
uveitis
colitis, ulcerative
antirheumatic agents
antirheumatic agents
Tumor Necrosis Factor Inhibitors
Tumor Necrosis Factor Inhibitors
biosimilar pharmaceuticals

---
https://www.has-sante.fr/jcms/p_3352220/fr/rotateq-vaccin-rotavirus-vivant-immunisation-active-des-nourrissons
2022
false
false
false
France
French
evaluation of the transparency committee
public health guidelines
infant
rotavirus vaccines
vaccination
RotaTeq
insurance, health, reimbursement
Vaccine Efficacy
administration, oral
gastroenteritis
rotavirus infections
Viral gastroenteritis caused by Rotavirus (disorder)
immunization schedule

---
https://www.has-sante.fr/jcms/p_3352176/fr/rotarix-rotavirus-humain-immunisation-active-des-nourrissons
2022
false
false
false
France
French
evaluation of the transparency committee
public health guidelines
infant
Vaccine Efficacy
vaccination
immunization schedule
rotavirus infections
gastroenteritis
rotavirus vaccines
RIX4414 vaccine
administration, oral
Viral gastroenteritis caused by Rotavirus (disorder)
insurance, health, reimbursement

---
https://www.minerva-ebp.be/FR/Article/2270
2022
Belgium
critical appraisal or critical reading
resulting in
food
exercise
pregnancy outcome
birth weight
mother, nos
eating, nos
eating
Physics
increased body weight
pregnancy, nos
Food
physics
Gestational Weight Gain

---
https://www.has-sante.fr/jcms/p_3321070/fr/recommandation-vaccinale-contre-les-infections-a-rotavirus-revision-de-la-strategie-vaccinale-et-determination-de-la-place-des-vaccins-rotarix-et-rotateq
2022
France
public health guidelines
vaccination, nos
health planning guidelines
vaccination
RotaTeq
Vaccinia
RotaTeq
rotavirus, nos
vaccinia, nos
Vaccins
rotarix
infectious disease, nos
vaccines
vaccine, nos
rotavirus infections
preventive immunization/medication

---
https://www.santepubliquefrance.fr/regions/hauts-de-france/documents/enquetes-etudes/2022/toxi-infection-alimentaire-collective-tiac-a-e.-coli-o157-producteur-de-shiga-toxines-associee-a-la-consommation-de-concombres-crus
2022
France
technical report
Collection
Alimentary infection
community-acquired infections
toxin, nos
escherichia coli o157
cucumis, nos
infectious disease, nos
cucumis sativus
foodborne diseases
shiga toxins
economics
cucumbers

---
https://www.has-sante.fr/jcms/p_3358124/fr/infracyanine-vert-d-indocyanine-monopic-reperage-peroperatoire-du-ganglion-sentinelle
2022
false
false
false
France
coloring agents
insurance, health, reimbursement
diagnostic uses of chemicals
intraoperative period
indocyanine green
breast neoplasms
lymphatic system
evaluation of the transparency committee
Sentinel Lymph Node
indocyanine green

---
https://www.has-sante.fr/jcms/p_3358600/fr/imeth-methotrexate-disodique-maladie-de-crohn
2022
false
false
false
France
treatment outcome
insurance, health, reimbursement
injections, subcutaneous
methotrexate
immunosuppressive agents
adult
evaluation of the transparency committee
crohn disease
methotrexate

---
https://www.has-sante.fr/jcms/p_3359432/fr/ayvakyt-avapritinib-mastocytose-systemique-agressive-asm
https://www.has-sante.fr/jcms/p_3359458/fr/decision-n2022-0278/dc/sem-du-21-juillet-2022-du-college-de-la-haute-autorite-de-sante-portant-autorisation-d-acces-precoce-de-la-specialite-ayvakyt
2022
false
false
false
France
adult
Systemic Mastocytosis with an Associated Myeloid Neoplasm
protein kinase inhibitors
avapritinib
leukemia, mast-cell
treatment outcome
insurance, health, reimbursement
guidelines for drug use
continuity of patient care
administration, oral
evaluation of the transparency committee
avapritinib
aggressive systemic mastocytosis
mastocytosis, systemic

---
https://www.has-sante.fr/jcms/p_3359098/fr/opdivo-nivolumab-carcinome-urothelial
https://www.has-sante.fr/jcms/p_3359104/fr/decision-n2022-0246/dc/sem-du-13-juillet-2022-du-college-de-la-haute-autorite-de-sante-portant-autorisation-d-acces-precoce-de-la-specialite-opdivo
2022
false
false
false
France
treatment outcome
insurance, health, reimbursement
guidelines for drug use
infusions, intravenous
Antineoplastic Agents, Immunological
nivolumab
adult
Urothelial Carcinoma
evaluation of the transparency committee
Nivolumab

---
https://www.has-sante.fr/jcms/p_3358913/fr/jakavi-ruxolitinib-maladie-du-greffon
https://www.has-sante.fr/jcms/p_3358954/fr/decision-n2022-0214/dc/sem-du-30-juin-2022-du-college-de-la-haute-autorite-de-sante-portant-delegation-en-matiere-d-autorisation-d-acces-precoce-de-la-specialite-jakavi
2022
false
false
false
France
graft vs host disease
treatment outcome
insurance, health, reimbursement
adult
adolescent
administration, oral
evaluation of the transparency committee
ruxolitinib

---
https://ansm.sante.fr/informations-de-securite/cancer-epithelial-de-lovaire-des-trompes-et-du-peritoine-primitif-rucaparib-rubraca-ne-doit-plus-etre-utilise-en-3-ligne
2022
false
false
false
France
French
pharmacovigilance note
guidelines for drug use
survival analysis
rucaparib
rucaparib
treatment outcome
ovarian neoplasms
fallopian tube neoplasms
peritoneal neoplasms
Maintenance Therapy

---
https://ansm.sante.fr/actualites/decision-du-27-07-2022-modification-du-cadre-de-prescription-compassionnelle-du-medicament-lutathera-370-mbq-ml-solution-pour-perfusion
2022
false
false
false
France
French
drug information
legislation, pharmacy
infusions, intravenous
lutetium Lu 177 dotatate

---
https://ansm.sante.fr/tableau-marr/hemine-humaine
2022
false
false
false
France
French
risk management
hemin
guidelines for drug use
continuity of patient care
infusions, intravenous
Drug-Related side effects and adverse reactions
Injection Site Reaction
hemin

---
https://www.has-sante.fr/jcms/p_3359829/fr/enhertu-trastuzumab-deruxtecan-cancer-estomac
2022
false
false
false
France
Antineoplastic Agents, Immunological
trastuzumab deruxtecan
antibodies, monoclonal, humanized
immunoconjugates
camptothecin
insurance, health, reimbursement
treatment outcome
stomach neoplasms
adenocarcinoma
Gastric Adenocarcinoma
Gastroesophageal Junction Adenocarcinoma
esophagogastric junction
HER2/Neu Positive
HER2 positive gastric cancer
adult
infusions, intravenous
evaluation of the transparency committee
Trastuzumab
trastuzumab deruxtecan

---
https://www.has-sante.fr/jcms/p_3363308/fr/remsima-infliximab-psoriasis-en-plaques-de-l-adulte
2022
false
false
false
France
treatment outcome
insurance, health, reimbursement
Infliximab
psoriasis
infliximab
dermatologic agents
Tumor Necrosis Factor Inhibitors
injections, subcutaneous
adult
evaluation of the transparency committee

---
https://www.has-sante.fr/jcms/p_3311628/fr/opdivo-nivolumab-cancer-de-l-oesophage-ou-de-la-jonction-oeso-gastrique
https://www.has-sante.fr/jcms/p_3311642/fr/decision-n-2022-0029/dc/sem-du-24-janvier-2022-de-la-presidente-de-la-haute-autorite-de-sante-prise-au-nom-du-college-portant-autorisation-d-acces-precoce-de-la-specialite-opdivo
2022
false
false
false
France
adult
stomach neoplasms
nivolumab
treatment outcome
insurance, health, reimbursement
esophagogastric junction
infusions, intravenous
evaluation of the transparency committee
esophageal neoplasms
esophagogastric junction
Nivolumab
nivolumab

---
https://www.has-sante.fr/jcms/p_3308678/fr/opdivo/yervoy-nivolumab/ipilimumab-mesotheliome-pleural-malin
2022
false
false
false
France
treatment outcome
insurance, health, reimbursement
infusions, intravenous
Unresectable Pleural Malignant Mesothelioma
Ipilimumab
Nivolumab
Ipilimumab/Nivolumab Regimen
survival analysis
Antineoplastic Agents, Immunological
antineoplastic combined chemotherapy protocols
evaluation of the transparency committee
Malignant Pleural Mesothelioma
Mesothelioma, Malignant

---
Nous contacter.
01/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.